Based on SEC filing data. A biotech corporation founded in 2020 and based in London raised $992,645 through a convertible note. The company is in the pre-seed stage of development.
Get notified the moment Virocell Biologics Ltd files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.